EC Healthcare announced preliminary unaudited sales results for the period from 1 October 2023 to 31 December 2023. For the quarter, the company's overall sales Volume is 7%+.
Delayed
Other stock markets
|
5-day change | 1st Jan Change | ||
1.25 HKD | -1.57% |
|
-9.42% | -28.16% |
20/06 | EC Healthcare Forecasts Profit Drop in FY2024; Shares Down 7% | MT |
19/06 | EC Healthcare Provides Consolidated Earnings Guidance for the Year Ended March 31, 2024 | CI |
![Consensus](/images/consensus_flch.gif)
EPS Revisions
1st Jan change | Capi. | |
---|---|---|
-28.16% | 20Cr | |
-24.50% | 53Cr | |
+44.40% | 48Cr | |
-26.97% | 39Cr | |
-10.78% | 25Cr | |
-23.07% | 9.52Cr | |
-0.11% | 8.17Cr | |
+40.47% | 7.84Cr | |
-13.93% | 6.89Cr | |
-16.55% | 6.2Cr |
- Stock Market
- Equities
- 2138 Stock
- News EC Healthcare
- EC Healthcare Announces Preliminary Unaudited Sales Results for the Period from 1 October 2023 to 31 December 2023